Observational Study to Characterize Biomarkers and Disease Progression in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Clinical trial NCT06014541 · TERMINATED
Trial details
- NCT number
- NCT06014541
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-03
- Primary completion
- 2025-10-07
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.